BridgeMD
New treatment option for Diabetic Peripheral Neuropathy
Official title Shortwave Intervention for Diabetic Peripheral Neuropathy.
ClinicalTrials.gov ID: NCT07625007
What this study is testing
- What it's testing
- This study is a single-center, randomized, single-blind, sham-controlled clinical trial aimed at evaluating the efficacy and safety of shortwave therapy administered for five consecutive days in the treatment of diabetic peripheral neuropathy. The study plans to enroll 202 patients, who will be randomly assigned in a 1:1 ratio to either the shortwave therapy group (20 minutes daily for five consecutive days) or a sham treatment group with an identical appearance.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- 1\. Aged 18-85 years, regardless of gender, with the ability to act independently;
- 2\. Appearance of neuropathic symptoms or signs at the time of or after the diagnosis of diabetes, meeting the following criteria: presence of DPN...
- 3\. Able to complete the TCSS assessment;
- 4\. Understands the entire trial process, voluntarily participates in the study, and signs the informed consent form.
- 5\. Patients who did not respond to adequate treatment with mecobalamin and other medications.
You likely can't join if
- 1\. Peripheral neuropathy caused by other reasons (such as lumbar spine lesions, vitamin B12 deficiency, uncontrolled hypothyroidism, alcohol...
- 2\. Hemorrhagic diseases, malignant tumors;
- 3\. History of below-knee amputation;
- 4\. Skin damage, infection at the treatment site, or presence of metal implants, pacemaker;
- 5\. Combined severe heart, liver, or kidney dysfunction (e.g., eGFR \< 15 ml/min/1.73m²), or cognitive impairment preventing cooperation;
- 6\. Pregnancy, breastfeeding, or planning pregnancy;
See the full eligibility criteria
- 1\. Aged 18-85 years, regardless of gender, with the ability to act independently;
- 2\. Appearance of neuropathic symptoms or signs at the time of or after the diagnosis of diabetes, meeting the following criteria: presence of DPN symptoms (numbness, tingling, burning, cold, pain), with or without...
- 3\. Able to complete the TCSS assessment;
- 4\. Understands the entire trial process, voluntarily participates in the study, and signs the informed consent form.
- 5\. Patients who did not respond to adequate treatment with mecobalamin and other medications.
- 1\. Peripheral neuropathy caused by other reasons (such as lumbar spine lesions, vitamin B12 deficiency, uncontrolled hypothyroidism, alcohol intoxication, drug neurotoxicity, Guillain-Barré syndrome, etc.);
- 2\. Hemorrhagic diseases, malignant tumors;
- 3\. History of below-knee amputation;
- 4\. Skin damage, infection at the treatment site, or presence of metal implants, pacemaker;
- 5\. Combined severe heart, liver, or kidney dysfunction (e.g., eGFR \< 15 ml/min/1.73m²), or cognitive impairment preventing cooperation;
- 6\. Pregnancy, breastfeeding, or planning pregnancy;
- 7\. Participation in other treatment clinical trials within the past 3 months;
- 8\. Combined severe psychiatric disorders;
- 9\. Other conditions assessed by the investigator that prevent completion of the trial;
- 10\. Poor compliance.
The study team makes the final eligibility decision.
Where it's taking place
- Chongqing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chongqing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.